Envestnet Portfolio Solutions’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$511K Buy
7,691
+3,352
+77% +$284K ﹤0.01% 981
2026
Q1
$431K Sell
4,339
-363
-8% -$47.3K ﹤0.01% 964
2025
Q4
$572K Buy
4,702
+207
+5% +$26K ﹤0.01% 997
2025
Q3
$504K Buy
4,495
+324
+8% +$37.9K ﹤0.01% 1026
2025
Q2
$559K Buy
+4,171
New +$458K ﹤0.01% 1045
2025
Q1
– Sell
-4,721
Closed -$294K – 1763
2024
Q4
$294K Buy
4,721
+317
+7% +$29.5K ﹤0.01% 1517
2024
Q3
$691K Sell
4,404
-322
-7% -$49.6K ﹤0.01% 1047
2024
Q2
$712K Sell
4,726
-1,389
-23% -$167K ﹤0.01% 986
2024
Q1
$452K Sell
6,115
-146
-2% -$12K ﹤0.01% 1164
2023
Q4
$494K Buy
6,261
+2,551
+69% +$154K ﹤0.01% 1061
2023
Q3
$203K Buy
+3,710
New +$267K ﹤0.01% 1429

Other funds holding TMDX

Envestnet Portfolio Solutions's TMDX Position: Q2 2026 in Review

Envestnet Portfolio Solutions increased its Transmedics (TMDX) stake by 77% in Q2 2026, buying an estimated $284K and bringing the position to 7,691 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Envestnet Portfolio Solutions first reported a position in TMDX in Q3 2023 and has held it in 11 quarters since. The position peaked at $712K in Q2 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Envestnet Portfolio Solutions held 7,691 shares of Transmedics worth $511K as of Q2 2026.
  • Envestnet Portfolio Solutions bought 3,352 Transmedics shares in Q2 2026, an estimated $284K.
  • Transmedics made up ﹤0.01% of Envestnet Portfolio Solutions's portfolio in Q2 2026, its #981 holding.
  • Envestnet Portfolio Solutions first reported a position in Transmedics in Q3 2023 and has held it in 11 quarters since.
  • Envestnet Portfolio Solutions's Transmedics position peaked at $712K in Q2 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Envestnet Portfolio Solutions's 13F filing for Q2 2026, filed 20 Jul 2026.